Monte Rosa Therapeutics I... (GLUE)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

7.60

0.86%

After-hours Dec 13, 2024, 06:37 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	-	-	-	-	-
Cost of Revenue	6.22M	8.56M	2.13M	537.00K	72.00K
Gross Profit	-6.22M	-8.56M	-2.13M	-537.00K	-72.00K
Operating Income	-143.31M	-112.38M	-72.88M	-28.01M	-7.99M
Interest Income	9.33M	3.76M	46.00K	9.00K	12.00
Pretax Income	-135.01M	-108.50M	-73.96M	-35.88M	-7.74M
Net Income	-135.35M	-104.62M	-71.94M	-36.07M	-8.02M
Selling & General & Admin	32.04M	27.32M	15.73M	4.00M	644.00K
Research & Development	111.27M	85.06M	57.16M	24.00M	7.35M
Other Expenses	-	-	-960.00K	-7.68M	276.00K
Operating Expenses	143.31M	112.38M	72.88M	28.01M	7.99M
Interest Expense	-	3.76M	-	-	1K
Selling & Marketing Expenses	-	-	-	-	-
Cost & Expenses	143.31M	112.38M	72.88M	28.01M	7.99M
Income Tax	338.00K	-3.88M	-2.02M	189.00K	277.00K
Shares Outstanding (Basic)	51.40M	47.23M	46.54M	44.00M	44.00M
Shares Outstanding (Diluted)	51.40M	47.23M	46.54M	44.00M	44.00M
EPS (Basic)	-2.63	-2.22	-1.55	-0.82	-0.18
EPS (Diluted)	-2.63	-2.22	-1.55	-0.82	-0.18
EBITDA	-137.09M	-99.94M	-70.75M	-27.47M	-7.67M
Depreciation & Amortization	6.22M	8.56M	2.13M	537.00K	72.00K